PTSD in Combat Vs. Peacekeeping Veterans


Anxiety disorders are associated with impaired emotional well-being as much among peacekeeping veterans as among combat veterans.

According to study results recently published in the Canadian Journal of Psychiatry by University of Western Ontario researchers, anxiety disorders such as post-traumatic stress disorder (PTSD) are associated with impaired emotional well-being as much among peacekeeping veterans as among combat veterans. Although PTSD is often prevalent among military members who have served in combat and war zones, the disorder had been less studied among deployed peacekeeping veterans. Lead study author, Dr. J. Donald Richardson, consultant psychiatrist, Operational Stress Injury Clinic at Parkwood Hospital, St. Joseph's Health Care, London, and psychiatry professor, Schulich School of Medicine & Dentistry, University of Western Ontario, and colleagues found that peacekeepers are put into traumatic situations that they are unable to prevent due to United Nation rules of engagement that say soldiers have to practice restraint and neutrality. An important risk factor for PTSD is the feeling of lack of control over traumatic situations.

“This finding is important to clinicians working with the newer generation of veterans, as it stresses the importance of including measures of quality of life when evaluating veterans to better address their rehabilitation needs,” said Dr. Richardson. “It is not enough to measure symptom changes with treatment; we need to objectively asses if treatment is improving their quality of life and how they are functioning in their community.”

For more on PTSD and other mental health issues among Armed Forces, visit, and look for an interview on the use of technology in the diagnosis and treatment of services members with PTSD, including information on what office-based psychiatrists can learn from this use of technology, in an upcoming issue of MDNG: Psychiatry Edition.

Related Videos
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
Depression Screening: Challenges and Solutions at the Primary Care Level
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
© 2024 MJH Life Sciences

All rights reserved.